Ethics of Health Research Supported by For-Profit Cannabis Companies: What Have We Learned from Big Tobacco?
- PMID: 30712358
- PMCID: PMC12039945
- DOI: 10.1513/AnnalsATS.201811-764LE
Ethics of Health Research Supported by For-Profit Cannabis Companies: What Have We Learned from Big Tobacco?
Comment in
-
Reply: Ethics of Health Research Supported by For-Profit Cannabis Companies: What Have We Learned from Big Tobacco?Ann Am Thorac Soc. 2019 Mar;16(3):397. doi: 10.1513/AnnalsATS.201812-850LE. Ann Am Thorac Soc. 2019. PMID: 30712357 No abstract available.
Comment on
-
Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.Ann Am Thorac Soc. 2018 Oct;15(10):1146-1158. doi: 10.1513/AnnalsATS.201803-198OC. Ann Am Thorac Soc. 2018. PMID: 30049223 Clinical Trial.
References
-
- Abdallah SJ, Smith BM, Ware MA, Moore M, Li PZ, Bourbeau J, et al. Effect of vaporized cannabis on exertional breathlessness and exercise endurance in advanced chronic obstructive pulmonary disease. a randomized controlled trial. Ann Am Thorac Soc . 2018;15:1146–1158. - PubMed
-
- Owram K. Bloomberg; Valued at $4.8 billion, pot firm Tilray posts $10 million sales. 28 Aug 2018 [accessed 2018 Aug 18]. Available from: https://www.bloomberg.com/news/articles/2018-08-28/valued-at-4-8-billion....
-
- Malone RE. Changing Tobacco Control’s policy on tobacco industry-funded research. Tob Control . 2013;22:1–2. - PubMed
-
- Rabin RC.Major study of drinking will be shut down. New York Times . 2018 June 15;Sect A:17.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
